Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for bleeding reduction during septorhinoplasty
IRCT20171228038117N3Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of tranexamic acid in Nasal septum disorder (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Amount of bleeding during the operation, Complications during and after surgery and 1 more. Started May 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Nasal septum disorder
Beyond the preview
Go deeper on IRCT20171228038117N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171228038117N3.